하이페리온 디파이(HYPD)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $3.82 (+10.09%), 시가총액 $0.05B, 52주 최저~최고 $1.40 ~ $15.97.
Hyperion DeFi, Inc. operates as a digital asset treasury and ophthalmic technology company in the United States. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It also develops the Optejet User Filled Device for horizontal, microdose spray delivery of ophthalmic liquids, such as artificial tears and lens rewetting products, as well as related topical ocular therapies. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is bas
하이페리온 디파이의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
하이페리온 디파이의 현재 주가는 $3.82 (+10.09%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
하이페리온 디파이의 시가총액은 약 $0.05B입니다.
Hyperion DeFi, Inc. operates as a digital asset treasury and ophthalmic technology company in the United States. It operates through two segments: Ophthalmic Technology and Digital Assets. The company